Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Sensible Biotechnologies announced it raised $13.5 Million in an initial filing from an offering of $15 Million
PRIVATESep 02, 2026•5 days ago
Amount Raised
$13.5 Million
Round Type
Venture - Series Unknown
OxfordBiotechnology
Company Information
Company
Sensible Biotechnologies
Location
2093 Philadelphia Pike #3008
Oxford, Mississippi, United States
About
Sensible Biotechnologies is building a cell-based platform for the production of high-quality mRNA. Sensible's platform eliminates the major bottlenecks in the mRNA production process in an effort to unlock the full potential of mRNA technology for the next generation of therapeutics and vaccines. Sensible aims to become an integral part of the global biomanufacturing infrastructure and biosecurity framework. Sensible Biotechnologies is based in Oxford, United Kingdom, and in Bratislava, Slovakia. For further information, visit www.sensible.bio, and follow us on Twitter @sensible_bio.
Don't miss Sensible Biotechnologies's next move
Get an email the moment Sensible Biotechnologies raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Verified contactsMarian K., Executive Officer, Director
Predictive Intelligence
Strategic
ML-powered predictions for Sensible Biotechnologies's next move
OxfordBiotechnology